共 27 条
[3]
CARLIN JR, 1997, DRUG METAB DISPOS, V251, P100
[4]
CHANG MM, 1970, J BIOL CHEM, V245, P4784
[5]
DEAN B, 2000, DRUG METAB REV S2, V32, P267
[6]
Dear GJ, 1998, RAPID COMMUN MASS SP, V12, P2023, DOI 10.1002/(SICI)1097-0231(19981230)12:24<2023::AID-RCM431>3.0.CO
[7]
2-6
[8]
Ehlhardt WJ, 1998, DRUG METAB DISPOS, V26, P42
[9]
Structural optimization affording 2-(R)-(1-(R)-3,5-bis(trifluoromethyl)phenylethoxy)-3-(S)-(4-fluoro)phenyl-4-(3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a potent, orally active, long-acting morpholine acetal human NK-1 receptor antagonist
[J].
JOURNAL OF MEDICINAL CHEMISTRY,
1998, 41 (23)
:4607-4614